MBOT

Microbot Medical Inc.

1.27 USD

Last updated Dec 8, 05:21 UTC

Yesterday HIGH

$1.26

Yesterday LOW

$1.2

52w HIGH

$4.65

52w LOW

$1

EPS

-0.21

PE

-6.05

Next Earnings

Apr 1, 2024

Overview News Government Trades

Microbot Medical Inc. stock is down -15.33% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 31 December’s closed higher than November.

Microbot Medical Inc. engages in the research, design, and development of robotic endoluminal surgery devices. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Hingham, United States Of America

Website

www.microbotmedical.com

Benzinga Insights

Wed Jun 7, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Newsdesk

Tue Jun 6, 2023

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $8 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $8 price target.
Happy Mohamed

Fri Jun 2, 2023

Microbot Medical Announces $1.5M Registered Direct Offering Of 701,756 Shares Of Common Stock At A Price Of $2.1375/Share, Priced At-The-Market Under Nasdaq Rules

Microbot Medical Inc. (NASDAQ:MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company's common stock at a purchase price
Happy Mohamed

Fri Jun 2, 2023

Microbot Medical Receives A Non-Dilutive $440,000 Grant From The Israel Innovation Authority Supporting The Development Of The Manufacturing Process For Its Endovascular Surgical Robotic System

Microbot Medical Inc. (NASDAQ:MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, announced it has received a grant from the Israel
Happy Mohamed

Wed May 31, 2023

Microbot Medical Inc., The Developer Of The LIBERTY Robotic Surgical System Achieved Additional Milestone In Its Path To First In Human And Regulatory Process

Microbot Medical Inc. (NASDAQ:MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular surgical robotic system, announces that an additional milestone was achieved when
Happy Mohamed

Thu May 25, 2023

Lahey Hospital & Medical Center Agrees To Become One Of The U.S. Sites For The LIBERTY Robotic System's First Human Trial

This Significant Achievement Represents Major Progression Toward Regulatory and Commercialization Paths Additional Sites in the U.S. Are Expected to Participate in the Trial HINGHAM, Mass., May 25, 2023
Benzinga Newsdesk

Tue May 23, 2023

Microbot Medical Shares Resume Trade
Benzinga Newsdesk

Tue May 23, 2023

Microbot Medical Shares Halted On Circuit Breaker To The Downside, Stock Now Down -22.3%
Benzinga Newsdesk

Tue May 23, 2023

Microbot Medical Announces $2.66M Registered Direct Offering Of ~1.21M Shares Of Common Stock Priced At $2.20/Share At-The-Market Under Nasdaq Rules

Microbot Medical Inc. (NASDAQ:MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,209,500 shares of the Company's common stock (or common stock equivalents) at a purchase
Lisa Levin

Tue May 23, 2023

Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers

LULU $451.91 USD

AMD $128.14 USD

SAVA $20.82 USD

AAMC AAMC $5.09 USD

FLYW $22.44 USD

FANH FANH $6.76 USD